Date: 2017-01-26
Type of information: Opening of new premises
Compound:
Company: Cyprotex (UK), an Evotec company (Germany)
Therapeutic area: Technology - Services
Type agreement: opening of new premises
Action mechanism:
Disease:
Details: • On January 26, 2017, Cyprotex, a company wholly owned by Evotec, has completed the relocation of its UK operations from Macclesfield to Alderley Park. The move will consolidate Cyprotex’ UK operations into a single, state-of-the-art facility enabling its continued business growth. Part of Manchester Science Partnerships, Alderley Park is a scientific hub which is home to a network of over 150 biotech and life science companies. The facility to which Cyprotex has relocated to covers approx. 2,300 m² of office and laboratory space and will accommodate all 106 of Cyprotex’ current UK staff.
Financial terms:
Latest news:
